Abstract
Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Thrombosis and Haemostasis |
| Vol/bind | 9 |
| Udgave nummer | 8 |
| Sider (fra-til) | 1460-7 |
| Antal sider | 8 |
| ISSN | 1538-7933 |
| DOI | |
| Status | Udgivet - 1 aug. 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS